title: DNA and PCNA content of renal cell carcinoma and prognosis.
abstract: Robson stage I or II renal carcinomas have a heterogenous clinical outcome. A variety of morphologic features and other parameters have been proposed as prognostically useful. The authors measured the DNA content and PCNA expression of 47 stage I or II renal carcinomas, and assessed the association of these measures with pathologic stage, nuclear grade, and clinical course. Approximately 56% of stage I neoplasms and 40% of stage II neoplasms were diploid. Five of 9 neoplasms in which multiple samples were analyzed manifested both aneuploid and diploid regions. PCNA expression was noted in 20 of 32 stage I neoplasms and 9 of 15 stage II neoplasms, and varied greatly among the neoplasms. Neither ploidy nor PCNA expression is associated with clinical behavior in these data. These results are different from some of those previously reported by others. These discrepancies are likely to be due to differences in methodology and the fact that there were only eight cases of metastatic disease. No single parameter will serve as a completely accurate prognostic indicator. Most individuals with these neoplasms will do well because all of the tumor has been excised.
authors: Department of Pathology, University of Michigan School of Medicine, Ann Arbor 48105-3054.
authors: A
authors: A
authors: Flint
authors: H B
authors: HB
authors: Grossman
authors: M
authors: M
authors: Liebert
authors: R V
authors: RV
authors: Lloyd
authors: J
authors: J
authors: Bromberg
mesh_terms: D002292:Carcinoma, Renal Cell / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology*; D004273:DNA, Neoplasm / Q000378:metabolism*; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology*; D009367:Neoplasm Staging; D011003:Ploidies; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism*
chemical_list: D004273:DNA, Neoplasm; D018809:Proliferating Cell Nuclear Antigen